4.7 Article

Large Artery Stiffening and Remodeling Are Independently Associated With All-Cause Mortality and Cardiovascular Events in Chronic Kidney Disease

期刊

HYPERTENSION
卷 60, 期 6, 页码 1451-U222

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/HYPERTENSIONAHA.112.197210

关键词

renal insufficiency; remodeling; carotid artery common; aortic stiffness; mortality

资金

  1. French Ministry of Health [AOM 09114]
  2. Delegation a la Recherche Clinique
  3. Assistance Publique-Hopitaux de Paris
  4. Programme Hospitalier de Recherche Clinique [AOM 03023P030439]
  5. French Ministry of Research [01 P 0512]
  6. Inserm [AO 8022LS, GIS-IReSP AO 8113LS TGIR]
  7. Agence de Biomedecine [R08156LL/RP018156LLA]
  8. Roche [2009-152-447G]
  9. Association pour l'Utilisation du Rein Artificiel, AURA, Paris
  10. Affymax
  11. Genzyme
  12. Hoffmann-La Roche
  13. Novartis
  14. Sandoz
  15. Shire
  16. Takeda
  17. Vifor International
  18. Otsuka Ltd.
  19. Roche

向作者/读者索取更多资源

Chronic kidney disease, even at moderate stages, is characterized by a high incidence of cardiovascular events. Subclinical damage to large arteries, such as increased arterial stiffness and outward remodeling, is a classical hallmark of patients with chronic kidney disease. Whether large artery stiffness and remodeling influence the occurrence of cardiovascular events and the mortality of patients with chronic kidney disease (stages 2-5) is still debated. This prospective study included 439 patients with chronic kidney disease (mean age, 59.8 +/- 14.5 years) with a mean measured glomerular filtration rate of 37 mL/min per 1.73 m(2). Baseline aortic stiffness was estimated through carotid-femoral pulse wave velocity measurements; carotid stiffness, diameter, and intima-media thickness were measured with a high-resolution echotracking system. For the overall group of patients, the 5-year estimated survival and cumulative incidence of cardiovascular events were 87% and 16%, respectively. In regression analyses adjusted on classical cardiovascular and renal risk factors, aortic stiffness remained significantly associated with all-cause mortality (for 1 SD, Cox model-derived relative risk [95% CI], 1.48 [1.09-2.02]) and with fatal and nonfatal cardiovascular events (for 1 SD, Fine and Gray competing risks model-derived relative risk [95% CI], 1.35 [1.05-1.75]). Net reclassification improvement index was significant (29.0% [2.3-42.0%]). Carotid internal diameter was also independently associated with all-cause mortality. This study shows that increased aortic stiffness and carotid internal diameter are independent predictors of mortality in patients with stages 2 to 5 chronic kidney disease and that aortic stiffness improves the prediction of the risk. (Hypertension. 2012;60:1451-1457.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据